N/A
Completed N=11
Rutgers Pilot for PREDICT- Patient LAB Test
SARS-CoV2 Infection
Source: ClinicalTrials.gov NCT05607043 ↗
Enrolled (actual)
11
Serious AEs
0.0%
Results posted
Sep 2023
Primary outcomePrimary: Patient Willingness to Participate in the Study — 30 percentage
Summary
A pilot study was initiated to assess feasibility of testing asymptomatic dental patients presenting to the Oral Medicine Clinic at Rutgers School of Dental Medicine for SARS-CoV-2 viral RNA using an FDA approved RT-PCR test for SARS-CoV2- an RNA RT-PCR assay (Accurate Diagnostics)
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Patient Willingness to Participate in the Study |
30 | — |
| PRIMARY Willingness/Ability to Follow Through With the Study With Surveys, Triage and Testing |
9 | — |
| PRIMARY Patient Test Completion |
10 | — |
| PRIMARY Percentage of Subjects Who Complete Study Activities to Optimize Gap Between Testing and Study Visit |
9 | — |
| PRIMARY Ease of Complying With Protocol |
8 | — |
| PRIMARY Percent of Patients Who Completed All of the Required Surveys |
9 | — |
Eligibility Criteria
Inclusion Criteria
- Adult 18 years or older; reporting to the Rutgers School of Dental Medicine for a dental visit
Exclusion Criteria
- Previous participation
Data sourced from ClinicalTrials.gov (NCT05607043). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.